Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer | Synapse

February 8, 2018Open Access

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Among men with nonmetastatic castration-resistant prostate cancer, metastasis-free survival and time to symptomatic progression were significantly longer with apalutamide than with placebo. (Funded by Janssen Research and Development; SPARTAN ClinicalTrials.gov number, NCT01946204 .).

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Smith et al. (Thu,) studied this question.

synapsesocial.com/papers/69dd258403ecda3005e52d50 https://doi.org/https://doi.org/10.1056/nejmoa1715546